BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Imanova Selected For New £650K G8 Dementia Summit Translational Research Project


12/13/2013 10:11:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

London, December 13, 2013: Imanova Limited will be supporting the MRC UK Dementia Research Platform (UKDP) by providing their expertise in clinical imaging in a major new study of biomarkers for Alzheimer’s disease.

Led by Professor Simon Lovestone of King’s College London and Oxford University and using Imanova’s acknowledged expertise in novel tracers, imaging and analysis, the research will identify biomarkers for Alzheimer’s disease in pre-clinical patients. This will in turn enable early intervention, increasingly believed to be the key to successful treatment outcomes.

Kevin Cox, CEO at Imanova Limited, outlined the value of combining Imanova’s expertise within novel research concepts.

“As the use of imaging biomarkers grows, we hope to collaborate in more studies like these providing our expertise to augment understanding and visualise research.” stated Cox, “Being named as a full collaborator is a huge achievement for Imanova and it is encouraging to see that the UKDP will incorporate partnerships with pharmaceutical companies, SMEs and academia as a means to improve treatment and care in dementias.”

If successful, this initial study will lead into a larger programme within the UKDP.

About Imanova

Imanova Limited – the centre of excellence for imaging sciences, is a unique concept established to drive creativity and innovation in imaging sciences. Imanova is the former GSK Clinical Imaging Centre, which is now an independent company owned by a consortium of three world-class London universities (Imperial College, Kings College and University College London) and the UK’s Medical Research Council. Imanova's objective is to build on the reputation of the Clinical Imaging Centre as a leading centre for the application of imaging technology, become the international ‘partner of choice’ for pharma and biotech in the application of imaging to drug development, and to operate to the highest standards of quality and compliance as defined by leading external regulatory bodies. Imanova is located at Imperial College London’s Hammersmith Hospital campus.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Imanova
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES